SHARE THIS VIDEO —
Pfizer reports promising results in first phase of vaccine trial
This version of Mmvo86684229659 - Breaking News | NBC News Clone was adapted by NBC News Clone to help readers digest key facts more efficiently.
The trial gave 24 of its 45 participants two doses of the coronavirus vaccine, and all 24 produced antibodies. The vaccine will undergo two more trials before possible approval, which Pfizer hopes to get by the end of the year.
Want more summaries like this? Follow NBC News Clone for expertly filtered news from trusted sources.
